Moneycontrol PRO
you are here: HomeNewsAarti drugs
aarti drugs
Jump to
91 Results Found
  • Buy Aarti Drugs; target of Rs 844: Anand Rathi Aug 04, 2021 04:37 PM IST

    Buy Aarti Drugs; target of Rs 844: Anand Rathi

    Anand Rathi is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 844 in its research report dated July 28, 2021.

  • Aarti Drugs Standalone June 2021 Net Sales at Rs 505.79 crore, up 6.36% Y-o-Y Jul 28, 2021 11:00 AM IST

    Aarti Drugs Standalone June 2021 Net Sales at Rs 505.79 crore, up 6.36% Y-o-Y

  • Aarti Drugs Consolidated June 2021 Net Sales at Rs 579.95 crore, up 6.48% Y-o-Y Jul 28, 2021 11:00 AM IST

    Aarti Drugs Consolidated June 2021 Net Sales at Rs 579.95 crore, up 6.48% Y-o-Y

  • Aarti Drugs share price jumps 15% as board approves buyback worth up to Rs 60 crore Mar 19, 2021 03:23 PM IST

    Aarti Drugs share price jumps 15% as board approves buyback worth up to Rs 60 crore

    The board of directors has set the record date for the proposed buyback as April 1, 2021

  • Aarti Drugs' board to consider shares buyback later this week Mar 16, 2021 10:39 AM IST

    Aarti Drugs' board to consider shares buyback later this week

    A meeting of the Board of Directors of the company is scheduled to be held on Friday, March 19, 2021, to consider the proposal of buyback of the fully paid-up equity shares of the company, Aarti Drugs said in a regulatory filing.

  • Aarti Drugs share price gains 6% on share buyback plan Mar 16, 2021 10:07 AM IST

    Aarti Drugs share price gains 6% on share buyback plan

    The share touched a 52-week high of Rs 1,025 and a 52-week low of Rs 105.56 on 08 October, 2020 and 19 March, 2020, respectively.

  • Aarti Drugs share price jumps 7% as arm gets approval under pharma PLI scheme Mar 08, 2021 10:25 AM IST

    Aarti Drugs share price jumps 7% as arm gets approval under pharma PLI scheme

    The share touched a 52-week high of Rs 1,026.95 and a 52-week low Rs 105.25 on 08 October 2020 and 23 March 2020, respectively.

  • Buy Aarti Drugs; target of Rs 848: Anand Rathi Feb 01, 2021 06:12 PM IST

    Buy Aarti Drugs; target of Rs 848: Anand Rathi

    Anand Rathi is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 848 in its research report dated January 27, 2021.

  • Aarti Drugs Consolidated December 2020 Net Sales at Rs 530.25 crore, up 11.98% Y-o-Y Jan 27, 2021 09:33 AM IST

    Aarti Drugs Consolidated December 2020 Net Sales at Rs 530.25 crore, up 11.98% Y-o-Y

  • Aarti Drugs Standalone December 2020 Net Sales at Rs 472.10 crore, up 13.59% Y-o-Y Jan 27, 2021 09:33 AM IST

    Aarti Drugs Standalone December 2020 Net Sales at Rs 472.10 crore, up 13.59% Y-o-Y

  • Buy Aarti Drugs; target of Rs 813: Anand Rathi Nov 04, 2020 08:54 PM IST

    Buy Aarti Drugs; target of Rs 813: Anand Rathi

    Anand Rathi is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 813 in its research report dated October 28, 2020.

  • Aarti Drugs Consolidated September 2020 Net Sales at Rs 578.11 crore, up 21.07% Y-o-Y Oct 27, 2020 09:41 AM IST

    Aarti Drugs Consolidated September 2020 Net Sales at Rs 578.11 crore, up 21.07% Y-o-Y

  • Aarti Drugs Standalone September 2020 Net Sales at Rs 515.16 crore, up 16.37% Y-o-Y Oct 27, 2020 09:23 AM IST

    Aarti Drugs Standalone September 2020 Net Sales at Rs 515.16 crore, up 16.37% Y-o-Y

  • Aarti Drugs Consolidated September 2020 Net Sales at Rs 578.11 crore, up 21.07% Y-o-Y Oct 26, 2020 08:25 PM IST

    Aarti Drugs Consolidated September 2020 Net Sales at Rs 578.11 crore, up 21.07% Y-o-Y

  • Aarti Drugs Standalone September 2020 Net Sales at Rs 515.16 crore, up 16.37% Y-o-Y Oct 26, 2020 08:00 PM IST

    Aarti Drugs Standalone September 2020 Net Sales at Rs 515.16 crore, up 16.37% Y-o-Y

  • Fresh highs possible in ICICI Securities in next 4-6 months; here’s why Sep 15, 2020 12:01 PM IST

    Fresh highs possible in ICICI Securities in next 4-6 months; here’s why

    Companies having promoter integrity, high sector tailwinds, sales and profit growth sustenance, margins improvement are must to have which is what our 5GCPM framework focuses upon.

  • Aarti Drugs share price surges 18% in 2 days, hits new 52-week high after Board approves issuance of bonus shares Aug 21, 2020 10:22 AM IST

    Aarti Drugs share price surges 18% in 2 days, hits new 52-week high after Board approves issuance of bonus shares

    The Board of Directors have approved the issuance of fully paid-up bonus shares in the ratio of 3:1

  • Aarti Drugs stock surges 13% to hit 52-week high after Board approves issuance of bonus shares Aug 20, 2020 02:31 PM IST

    Aarti Drugs stock surges 13% to hit 52-week high after Board approves issuance of bonus shares

    The stock price has surged over 57 percent in the last 15 days

  • Trade Spotlight: Aarti Drugs, Caplin Point & Aurobindo Pharma hit 52-week high, what should investors do? Aug 07, 2020 08:22 AM IST

    Trade Spotlight: Aarti Drugs, Caplin Point & Aurobindo Pharma hit 52-week high, what should investors do?

    Experts are of the view that investors should trade with caution, and a more sustainable move can be seen only a close above 11225. Immediate support is placed at 11,100 levels.

  • Buy Aarti Drugs; target of Rs 2090: Anand Rathi Jul 30, 2020 06:43 PM IST

    Buy Aarti Drugs; target of Rs 2090: Anand Rathi

    Anand Rathi is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 2090 in its research report dated July 28, 2020.

  • Aarti Drugs Consolidated June 2020 Net Sales at Rs 544.67 crore, up 34.34% Y-o-Y Jul 28, 2020 09:33 AM IST

    Aarti Drugs Consolidated June 2020 Net Sales at Rs 544.67 crore, up 34.34% Y-o-Y

  • Aarti Drugs Standalone June 2020 Net Sales at Rs 475.55 crore, up 28.52% Y-o-Y Jul 28, 2020 09:33 AM IST

    Aarti Drugs Standalone June 2020 Net Sales at Rs 475.55 crore, up 28.52% Y-o-Y

  • Aarti Drugs Consolidated March 2020 Net Sales at Rs 449.64 crore, down 2.07% Y-o-Y May 21, 2020 09:16 AM IST

    Aarti Drugs Consolidated March 2020 Net Sales at Rs 449.64 crore, down 2.07% Y-o-Y

  • Buy Aarti Drugs; target of Rs 1028: Anand Rathi May 20, 2020 04:21 PM IST

    Buy Aarti Drugs; target of Rs 1028: Anand Rathi

    Anand Rathi is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 1028 in its research report dated May 19, 2020.

  • Aarti Drugs Consolidated March 2020 Net Sales at Rs 449.64 crore, down 2.07% Y-o-Y May 18, 2020 01:22 PM IST

    Aarti Drugs Consolidated March 2020 Net Sales at Rs 449.64 crore, down 2.07% Y-o-Y

Sections
ISO 27001 - BSI Assurance Mark